Reports
Sale
Asia Pacific Infertility Diagnostics Devices Market Size: By Product: Equipment, Media & Consumables, Accessories; By Procedure: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Fertility Surgeries, Others; By Patient Type: Female, Male; By Type; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Asia Pacific Infertility Diagnostics Devices Market Outlook
The global infertility diagnostics market size is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with Asia-Pacific having a significant contribution to market growth. The market is driven by the increasing prevalence of infertility in the region.
Key Takeaways
- According to a white paper released by Ferring Pharmaceuticals in November 2023, major Asian countries such as Singapore, Japan, and Taiwan, led by South Korea, are experiencing an unparalleled decrease in fertility.
- One of the major Asia Pacific infertility diagnostics devices market trends includes noteworthy innovations and product launches for infertility diagnosis. In December 2023, Arva Health launched a new diagnostic tool targeting Indian women with health concerns such as PCOS and thyroid to track their reproductive health.
- Government funding activities are impacting the infertility diagnostics devices market in the Asia Pacific region. For instance, the Mechanobiology Institute (MBI) at the National University of Singapore received a funding of around USD 36 million for innovating age-related conditions including infertility.
Asia Pacific Infertility Diagnostics Devices Market Analysis
In the Asia Pacific region, infertility is on the rise, which can be attributed to evolving lifestyle of the population. Unhealthy dietary habits, substance indulgence, deterioration of work life balance, and a sedentary lifestyle are amongst major causes for the condition. In November 2023, Ferring Pharmaceuticals surveyed 7 major regions of Asia to determine the decline in fertility rates, and to educate people about the importance of being aware of the availability of diagnostic facilities. The data registered through the survey showcased an unparalleled decline in fertility rates in the region, with major countries like South Korea, Japan and Singapore leading the charts. This decline in fertility rates is driving the Asia Pacific infertility diagnostics devices market share.
The market is further driven by the rise in the awareness initiatives to normalise infertility diagnostic tests. The government, along with non-profit organisations are setting up various awareness campaigns while also providing national financial coverage schemes for the same. The trend is noticeable in several emerging economies such as Singapore, Japan, South Korea, Indonesia, and Taiwan among others.
To meet the rising Asia Pacific infertility diagnostics devices market demand, there has been an influx of new product launches by market players significantly influencing the market growth. These new launches are personalised and provide insightful data about women's reproductive health, helpful in understanding how their fertility health is influenced by their lifestyle choices. For instance, in December 2023, an Indian health-tech company, Arva Health launched its at-home fertility test especially curated for Indian women suffering from PCOS and thyroid issues. The company aims to provide unprecedented insights to women about their reproductive hormones in comprehensive language including tests like anti-mullerian hormone AMH and Ovarian Reserve.
The Asia Pacific infertility diagnostics devices market growth is further fuelled by government funding for research and development of novel technologies and therapeutics for treating infertility. For instance, in January 2024, the National Research Foundation (NRF) offered a funding of SGD 49 million (nearly USD 36 million) to National University of Singapore (NUS) affiliated Mechanobiology Institute (MBI). The funding enables the scientists to explore and research on various aspects of human health and focus on developing more effective diagnostics for diseases as well. It marks a significant initiative to improve the healthcare infrastructure and incorporate latest research equipment in the region as well.
Asia Pacific Infertility Diagnostics Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Product | Equipment, Media and Consumables, Accessories |
| Procedure | In Vitro Fertilization, Intracytoplasmic Sperm Injection, Artificial Insemination, Fertility Surgeries, Others |
| Patient Type | Female and Male |
| Type | Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscope, Others |
| End User | Hospitals and Surgical Clinics, Cryobanks, Research Institutes, Others |
| Country | China, Japan, ASEAN, Australia, India, Others |
Asia Pacific Infertility Diagnostics Devices Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Group
- Vitrolife
- Thermo Fisher Scientific
- Hamilton Thorne LTD
- Esco Micro Pte Ltd
- Genea Limited
- IVFtech APS
- FIJIFILM Irvine Scientific
- The Baker Company INC
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Procedure |
|
| Breakup by Patient Type |
|
| Breakup by Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asia Pacific Infertility Diagnostics Devices Market Overview
3.1 Asia Pacific Infertility Diagnostics Devices Market Historical Value (2017-2023)
3.2 Asia Pacific Infertility Diagnostics Devices Market Forecast Value (2024-2032)
4 Asia Pacific Infertility Diagnostics Devices Market Landscape*
4.1 Asia Pacific Infertility Diagnostics Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Asia Pacific Infertility Diagnostics Devices: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Procedure
5 Asia Pacific Infertility Diagnostics Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Asia Pacific Infertility Diagnostics Devices Market Segmentation (2017-2032)
6.1 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Media & Consumables
6.1.4 Accessories
6.2 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Procedure
6.2.1 Market Overview
6.2.2 In Vitro Fertilization
6.2.3 Intracytoplasmic Sperm Injection
6.2.4 Artificial Insemination
6.2.5 Fertility Surgeries
6.2.6 Others
6.3 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Patient Type
6.3.1 Market Overview
6.3.2 Female
6.3.3 Male
6.4 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Type
6.4.1 Market Overview
6.4.2 Sperm Separation Devices
6.4.3 Ovum Aspiration Pumps
6.4.4 Sperm Analyzer Systems
6.4.5 Micromanipulator Systems
6.4.6 Incubators
6.4.7 Cryosystems
6.4.8 Imaging Systems
6.4.9 Microscope
6.4.10 Others
6.5 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Hospitals & Surgical Clinics
6.5.3 Cryobanks
6.5.4 Research Institutes
6.5.5 Others
6.6 Asia Pacific Infertility Diagnostics Devices Market (2017-2032) by Countries
6.6.1 Market Overview
6.6.1 China
6.6.2 Japan
6.6.3 ASEAN
6.6.4 Australia
6.6.5 India
6.6.6 Others
7 China Infertility Diagnostics Devices Market (2017-2032)
7.1 China Infertility Diagnostics Devices Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Equipment
7.1.3 Media & Consumables
7.1.4 Accessories
7.2 China Infertility Diagnostics Devices Market (2017-2032) by Procedure
7.2.1 Market Overview
7.2.2 In Vitro Fertilization
7.2.3 Intracytoplasmic Sperm Injection
7.2.4 Artificial Insemination
7.2.5 Fertility Surgeries
7.2.6 Others
7.3 China Infertility Diagnostics Devices Market (2017-2032) by Patient Type
7.3.1 Market Overview
7.3.2 Female
7.3.3 Male
7.4 China Infertility Diagnostics Devices Market (2017-2032) by Type
7.4.1 Market Overview
7.4.2 Sperm Separation Devices
7.4.3 Ovum Aspiration Pumps
7.4.4 Sperm Analyzer Systems
7.4.5 Micromanipulator Systems
7.4.6 Incubators
7.4.7 Cryosystems
7.4.8 Imaging Systems
7.4.9 Microscope
7.4.10 Others
7.5 China Infertility Diagnostics Devices Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Hospitals & Surgical Clinics
7.5.3 Cryobanks
7.5.4 Research Institutes
7.5.5 Others
8 Japan Infertility Diagnostics Devices Market (2017-2032)
8.1 Japan Infertility Diagnostics Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Equipment
8.1.3 Media & Consumables
8.1.4 Accessories
8.2 Japan Infertility Diagnostics Devices Market (2017-2032) by Procedure
8.2.1 Market Overview
8.2.2 In Vitro Fertilization
8.2.3 Intracytoplasmic Sperm Injection
8.2.4 Artificial Insemination
8.2.5 Fertility Surgeries
8.2.6 Others
8.3 Japan Infertility Diagnostics Devices Market (2017-2032) by Patient Type
8.3.1 Market Overview
8.3.2 Female
8.3.3 Male
8.4 Japan Infertility Diagnostics Devices Market (2017-2032) by Type
8.4.1 Market Overview
8.4.2 Sperm Separation Devices
8.4.3 Ovum Aspiration Pumps
8.4.4 Sperm Analyzer Systems
8.4.5 Micromanipulator Systems
8.4.6 Incubators
8.4.7 Cryosystems
8.4.8 Imaging Systems
8.4.9 Microscope
8.4.10 Others
8.5 Japan Infertility Diagnostics Devices Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Hospitals & Surgical Clinics
8.5.3 Cryobanks
8.5.4 Research Institutes
8.5.5 Others
9 ASEAN Infertility Diagnostics Devices Market (2017-2032)
9.1 ASEAN Infertility Diagnostics Devices Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Equipment
9.1.3 Media & Consumables
9.1.4 Accessories
9.2 ASEAN Infertility Diagnostics Devices Market (2017-2032) by Procedure
9.2.1 Market Overview
9.2.2 In Vitro Fertilization
9.2.3 Intracytoplasmic Sperm Injection
9.2.4 Artificial Insemination
9.2.5 Fertility Surgeries
9.2.6 Others
9.3 ASEAN Infertility Diagnostics Devices Market (2017-2032) by Patient Type
9.3.1 Market Overview
9.3.2 Female
9.3.3 Male
9.4 ASEAN Infertility Diagnostics Devices Market (2017-2032) by Type
9.4.1 Market Overview
9.4.2 Sperm Separation Devices
9.4.3 Ovum Aspiration Pumps
9.4.4 Sperm Analyzer Systems
9.4.5 Micromanipulator Systems
9.4.6 Incubators
9.4.7 Cryosystems
9.4.8 Imaging Systems
9.4.9 Microscope
9.4.10 Others
9.5 ASEAN Infertility Diagnostics Devices Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Hospitals & Surgical Clinics
9.5.3 Cryobanks
9.5.4 Research Institutes
9.5.5 Others
10 Australia Infertility Diagnostics Devices Market (2017-2032)
10.1 Australia Infertility Diagnostics Devices Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Equipment
10.1.3 Media & Consumables
10.1.4 Accessories
10.2 Australia Infertility Diagnostics Devices Market (2017-2032) by Procedure
10.2.1 Market Overview
10.2.2 In Vitro Fertilization
10.2.3 Intracytoplasmic Sperm Injection
10.2.4 Artificial Insemination
10.2.5 Fertility Surgeries
10.2.6 Others
10.3 Australia Infertility Diagnostics Devices Market (2017-2032) by Patient Type
10.3.1 Market Overview
10.3.2 Female
10.3.3 Male
10.4 Australia Infertility Diagnostics Devices Market (2017-2032) by Type
10.4.1 Market Overview
10.4.2 Sperm Separation Devices
10.4.3 Ovum Aspiration Pumps
10.4.4 Sperm Analyzer Systems
10.4.5 Micromanipulator Systems
10.4.6 Incubators
10.4.7 Cryosystems
10.4.8 Imaging Systems
10.4.9 Microscope
10.4.10 Others
10.5 Australia Infertility Diagnostics Devices Market (2017-2032) by End User
10.5.1 Market Overview
10.5.2 Hospitals & Surgical Clinics
10.5.3 Cryobanks
10.5.4 Research Institutes
10.5.5 Others
11 India Infertility Diagnostics Devices Market (2017-2032)
11.1 India Infertility Diagnostics Devices Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Equipment
11.1.3 Media & Consumables
11.1.4 Accessories
11.2 India Infertility Diagnostics Devices Market (2017-2032) by Procedure
11.2.1 Market Overview
11.2.2 In Vitro Fertilization
11.2.3 Intracytoplasmic Sperm Injection
11.2.4 Artificial Insemination
11.2.5 Fertility Surgeries
11.2.6 Others
11.3 India Infertility Diagnostics Devices Market (2017-2032) by Patient Type
11.3.1 Market Overview
11.3.2 Female
11.3.3 Male
11.4 India Infertility Diagnostics Devices Market (2017-2032) by Type
11.4.1 Market Overview
11.4.2 Sperm Separation Devices
11.4.3 Ovum Aspiration Pumps
11.4.4 Sperm Analyzer Systems
11.4.5 Micromanipulator Systems
11.4.6 Incubators
11.4.7 Cryosystems
11.4.8 Imaging Systems
11.4.9 Microscope
11.4.10 Others
11.5 India Infertility Diagnostics Devices Market (2017-2032) by End User
11.5.1 Market Overview
11.5.2 Hospitals & Surgical Clinics
11.5.3 Cryobanks
11.5.4 Research Institutes
11.5.5 Others
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 Cook Group
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Vitrolife
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Thermo Fisher Scientific
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Hamilton Thorne LTD
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Esco Micro Pte Ltd
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Genea Limited
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 IVFtech APS
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 FIJIFILM Irvine Scientific
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 The Baker Company INC
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
17 Asia Pacific Infertility Diagnostic Device Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The global infertility diagnostics market size is expected to grow at a CAGR of 8.8% during the forecast period of 2024-2032, with Asia-Pacific having a significant contribution to market growth.
The market demand is attributed to factors such as the rising prevalence of infertility, and increasing technological advancements in diagnostics, among others.
One of the significant trends in the market is the increasing government funding of research institutes to innovate and introduce novel technologies in domains such as infertility. In January 2024, the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) received an investment of around USD 36 million for the same purpose.
Products in the market include media and consumables, equipment, and accessories.
Procedures in the market include in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, fertility surgeries, and others.
The market includes both male and female patients.
Based on type, the market includes sperm separation devices, ovum aspiration pumps, sperm analyser systems, micromanipulator systems, incubators, cryosystems, imaging systems, and microscopes, among others.
End users in the market include hospitals and surgical clinics, cryobanks, and research institutes among others.
The market segmentation by countries includes China, Japan, ASEAN, Australia, India, and Others.
The key players in the market are Cook Group, Vitrolife, Thermo Fisher Scientific, Hamilton Thorne LTD, Esco Micro Pte Ltd, Genea Limited, IVFtech APS, FIJIFILM Irvine Scientific, and The Baker Company INC.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER